- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05119816
Music Therapy Intervention During Kidney Biopsy. (MTI-KB)
Effect of Music Therapy Intervention on Heart Rate, Anxiety and Pain During Kidney Biopsy: a Randomized Controlled Trial.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bari, Italy, 70124
- AOUConsorziale Policlinico Di Bari
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- age over 18 years
- not severe neurological or psychiatric conditions
- not hearing impairment
Exclusion Criteria:
- age under 18 years
- severe neurological or psychiatric conditions
- hearing impairment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control group
Patients receive standard care
|
|
|
Experimental: music therapy group
Patients receive an individual intervention of receptive music therapy during biopsy
|
Received a customize playlists prepared by a certified music therapist to listening to during KB
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
State Trait Anxiety Inventory Y-1
Time Frame: 30 minutes before biopsy
|
State Trait Anxiety Inventory Y-1(STAI-Y1) was used to measure how the subject felt in that moment.
Subjects were asked to rate the intensity of their anxious feelings on 20 items on a four point scale: not at all, somewhat, moderately so, or very much so.
STAI-Y values <40 defined absence of anxiety, between 40 and 50 mild anxiety, 51-60 moderate anxiety, and> 59 severe anxiety.
T0 30 minutes before biopsy
|
30 minutes before biopsy
|
|
State Trait Anxiety Inventory Y-1
Time Frame: 1 hour after biopsy
|
State Trait Anxiety Inventory Y-1(STAI-Y1) was used to measure how the subject felt in that moment.
Subjects were asked to rate the intensity of their anxious feelings on 20 items on a four point scale: not at all, somewhat, moderately so, or very much so.
STAI-Y values <40 defined absence of anxiety, between 40 and 50 mild anxiety, 51-60 moderate anxiety, and> 59 severe anxiety.
T1 1 hour after biopsy
|
1 hour after biopsy
|
|
visual analogic scale (VAS)
Time Frame: through study completion - 5 minutes after biopsy
|
A Visual Analogue Scale (VAS) is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured.VAS is usually a horizontal line, 100 mm in length, anchored by word descriptors at each end. The patient marks on the line the point that they feel represents their perception of their current state. The VAS score is determined by measuring in millimetres from the left hand end of the line to the point that the patient marks. |
through study completion - 5 minutes after biopsy
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
heart rate variability
Time Frame: during biopsy procedure
|
Heart rate variability (HRV) is a non-invasive measure reflecting the variation over time of the period between consecutive heartbeats (RR intervals) and has been proved to be a reliable marker of the autonomic nervous system(ANS) activity.
|
during biopsy procedure
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0033297/06/05/2020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kidney Diseases
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
University of North Carolina, Chapel HillLantheus Medical ImagingCompletedChronic Kidney Diseases | Cystic Kidney DiseaseUnited States
-
RenJi HospitalUnknownKidney Diseases,CysticChina
-
Pang PengGuangdong Provincial Hospital of Traditional Chinese MedicineUnknownEnd-Stage Kidney Disease | Chronic Kidney FailureChina
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
George Washington UniversityCareDx; VirginiaBio Analytics, LLCTerminatedKidney Diseases | Kidney Failure, Chronic | Kidney Transplant Infection | Kidney Transplant Rejection | Kidney Injury | Kidney Disease, Chronic | Kidney Failure | Kidney Failure, Acute | Kidney Transplant; Complications | Kidney IschemiaUnited States
-
Centre Hospitalier le MansLe Mans UniversiteWithdrawnFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage3 | Chronic Kidney Failure | Chronic Kidney Disease, Stage 4 (Severe)
-
A.C. AbrahamsCompletedEnd Stage Renal Disease | Chronic Kidney Disease | End Stage Kidney Disease | Chronic Kidney FailureNetherlands
-
Emory UniversityNorthwestern University; Columbia University; Satellite Healthcare; Norman S. Coplon...CompletedKidney Failure, Chronic | Kidney Transplantation | End-Stage Kidney DiseaseUnited States
-
Texas A&M UniversityWithdrawnChronic Kidney FailureUnited States
Clinical Trials on music therapy intervention
-
Icahn School of Medicine at Mount SinaiCompleted
-
University Diego PortalesRecruiting
-
Universidad Miguel Hernandez de ElcheCompletedCardiovascular Diseases | Emergencies | Critical Care | Music Therapy
-
Geisinger ClinicCompletedAlzheimer Disease | Lewy Body Disease | Frontotemporal Dementia | Behavioral and Psychiatric Symptoms of DementiaUnited States
-
Basque Health ServiceAGRUPARTE S.L.RecruitingRespiration, Artificial | Weaning | Music TherapySpain
-
Oncology Institute of Southern SwitzerlandNot yet recruitingLung Cancer (Suspected or Confirmed)Switzerland
-
Fundación Santa Fe de BogotaRecruitingStress | Burnout | Music Therapy | Quality of Life (QOL) | Humanization of CareColombia
-
Fundació Institut de Recerca de l'Hospital de la...Unknown
-
Christina Chianis ReedThe Methodist Hospital Research InstituteRecruitingMusic Therapy | Preterm Premature Rupture of Membrane (PPROM)United States
-
Università degli Studi del Piemonte Orientale "Amedeo...CompletedBreast Cancer | Oxidative Stress | Depression, AnxietyItaly